Plasma Cystine aminopeptidase (CAP) activities were examined in 40 pregnant and 10 nonpregnant Thoroughbred horses by spectrophotometric analysis using S-benzyl-L-Cystine-p dimethylaminoanilide as a substrate. Plasma CAP activities were remarkably low and no difference was observed between pregnant and non-pregnant horses. No changes of plasma CAP activities related with pregnant conditions, such as placental growth, functions and fetal growth, were observed. These results suggested that the plasma CAP activities seemed to be unavailable for the marker of maternal gestational conditions in horses.
Cystine aminopeptidase (CAP) [EC 3.4. 11.3] synthesized in placental syncytio trophoblast has been widely accepted to play an important role on the maintenance of gestation by inactivation of oxytocin in pregnant women [3, 8] . Since the enzym atic characteristics of plasma CAP is the same as those of placental CAP under cer tain inhibitory conditions, plasma CAP levels are considered to be closely related with placental weight and functions, and also with fetal growth [2, 10] . Plasma CAP activities in pregnant women increased remarkably at the late gestational period and these values were found to be available for estimating maternal gestational condi tions [4, 13] . Since plasma CAP showed identical inhibitory effects by certain con ditions to those of placental CAP in preg nant horses [7] (Sankyo Co., Ltd.) using S-benzyl-L--cystine-p-dimethylaminoanilide as a sub strate. Fig. 1 shows changes of plasma CAP activities in pregnant and non -pregnant horses. No difference was observed in the mean plasma CAP activities between preg nant and non-pregnant horses , however, those levels showed 3 peaks from May to July, from December to February, and April in both pregnant and non-pregnant horses. Babuna and Yenen [1] demon strated that the plasma CAP activity increased significantly after the 14th week of gestation and retained at high levels during pregnancy in women. These values were altered in certain pathologic pregnancies , decreased rapidly in intrauterine fetal death and also increased in the presence of multi ple pregnancy. However, Hrabak et al. [5] reported that plasma CAP activities in pregnant cows were very low and did not change with length of gestation , nor did it change when placentation was disrupted by infection with Aspergillus , fumigatus. The same results were also reported in pregnant rab bits, rats, and sheep [1, 13] . On the other hand, Hrabak et al. [6] demonstrated that plasma CAP activities in pregnant guinea pigs showed remarkably high and decreased with length of gestation, whereas increased significantly in women. In pregnant horses , plasma CAP showed same inhibitory effects by ethylene diamine tetra-acetic acid (EDTA), L-methionine, and heat treatment as those of placental CAP [7] like as those in women [8, 10 , 11] . However, no changes was observed during pregnancy in this study. Changes of plasma CAP activity in horses did not seem to result from the pregnant conditions. Grosser et al. [12] reported that the structure of placenta was classified into 4 types , hemochorial, endo theriochorial, syndesmochorial , and epi theliochorial placenta. The type of placental structure in the horse was classified into epitheliochorial placenta and was different from those of women classified to hemo chorial one. Changes of plasma CAP activities related with gcstational con ditions were considered to be different in maternal fetal blood barrier systems asso ciated with the type of placental structure . Further studies were necessary for esti mating of plasma CAP activity in pregnant horses from the point of view on the type of placental structure. No changes of arylamidase (AA) [EC 3.4.11 .2] activity related with gestational conditions was also observed in pregnant horses (data not shown). Since AA activity was detected in various tissues such as kidney , brain, liver, and also placenta [4] , many investigators reported that plasma AA activities showed no specificity to placental AA activities and also no relation with maternal pregnant conditions [4] . 
